Rovelizumab
Product Specifications
CAS Number
339086-79-2
Target
Integrin
Related Pathways
Cytoskeletal Signaling
Purity
0.95
Bioactivity
Rovelizumab (Hu23F2G) is a humanized monoclonal antibody targeting the cell adhesion molecule CD11/CD18. It inhibits overactive leukocytes during shock and may be used in studies of multiple sclerosis (MS), hemorrhagic shock, myocardial infarction, and stroke.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
